Avisi TechnologiesListed
avisitech.combiotech_life_sciences
Developing a nanotechnology-enabled glaucoma device.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Developing a nanotechnology-enabled glaucoma device.
Nanochon is an early-stage medical device company developing an innovative implant designed to address one of the most challenging problems in orthopedics: cartilage repair for pr…
Peptilogics is a surgical therapeutics company advancing a novel anti-biofilm drug designed to cure and prevent all medical device-related infections.
TYBR Health is dedicated to improving post-surgical recovery through its innovative product, B3 GEL, which prevents tissue tethering and enhances patient mobility after surgery.